V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320002944 | 320001757 | 1.65 | 57 | Adjuvant (A) | 2014-04-06 | 2014-04-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320017355 | CISPLATIN + ETOPOSIDE |
| 320002945 | 320004911 | 1.79 | 78.8 | Adjuvant (A) | 2014-12-31 | 2015-01-05 | Imatinib 400mg | 02 | N | 320017362 | NIVOLUMAB |
| 320002946 | 320006299 | 1.64 | 91.4 | Curative (C) | 2013-03-14 | 2013-03-14 | CISPLATIN + GEMCITABINE | N | N | 320017371 | BCG |
| 320002947 | 320001758 | 1.65 | 65 | Neo-adjuvant (N) | 2016-07-01 | 2016-07-18 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320017374 | STREPTOZOCIN + MDG |
| 320002948 | 320001759 | 0 | 50 | Neo-adjuvant (N) | null | 2014-05-07 | FLUOROURACIL + OXALIPLATIN | null | null | 320017378 | CARBOPLATIN + RT |
| 320002949 | 320001759 | 1.68 | 95.9 | null | null | 2016-12-22 | Trial Unspecified | null | null | 320017378 | CISPLATIN + GEMCITABINE |
| 320002950 | 320001759 | 1.78 | 63.5 | Palliative (P) | 2016-12-26 | 2016-12-26 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320017378 | CETUXIMAB + RT |
| 320002951 | 320001759 | 1.54 | 50.5 | Palliative (P) | 2017-12-07 | 2017-12-07 | Bevacizumab 7.5mg/kg | 02 | N | 320017378 | CETUXIMAB + RT |
| 320002952 | 320001759 | 1.58 | null | Neo-adjuvant (N) | 2016-09-13 | 2016-09-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320017378 | ICON TRIAL |
| 320002953 | 320001760 | 1.8 | 68 | Palliative (P) | 2017-06-13 | 2017-06-14 | CETUXIMAB | N | N | 320017416 | TEMOZOLOMIDE |
| 320002954 | 320001760 | null | 98.799 | null | 2014-08-08 | 2014-08-08 | CNS LGG 2004 03 con vinc +cisplatin | 2 | N | 320017416 | ICON8B TRIAL |
| 320002955 | 320001761 | null | 61.7 | Adjuvant (A) | 2015-10-21 | 2015-11-04 | FLUOROURACIL + IRINOTECAN | N | N | 320017423 | CARBOPLATIN + DOCETAXEL |
| 320002956 | 320004914 | 1.6 | 58.7 | Neo-adjuvant (N) | 2014-11-07 | 2014-11-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320017425 | CISPLATIN + GEMCITABINE |
| 320002957 | 320001762 | null | 0 | Palliative (P) | 2013-02-07 | 2013-02-21 | Oxaliplatin + Modified de Gramont | N | N | 320017435 | CARBOPLATIN + CETUXIMAB + FU |
| 320002958 | 320001763 | null | null | Adjuvant (A) | null | 2017-05-26 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 320017442 | CARBOPLATIN + VINORELBINE |
| 320002959 | 320001763 | 1.65 | 90 | Adjuvant (A) | 2014-07-05 | 2014-08-01 | Cisplatin + Pemetrexed | N | N | 320017442 | CARBOPLATIN + RT |
| 320002960 | 320006301 | 1.48 | 63.9 | Adjuvant (A) | 2013-07-31 | 2013-08-15 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 320017454 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320002961 | 320006937 | 1.77 | 51.6 | Palliative (P) | 2016-05-14 | 2016-05-29 | CETUXIMAB + RT | 02 | N | 320017455 | TRIAL |
| 320002962 | 320006937 | 1.69 | 86 | null | null | 2016-11-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320017455 | CISPLATIN + GEMCITABINE |
| 320002963 | 320001764 | 1.8 | null | Adjuvant (A) | 2017-10-06 | 2017-10-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320017457 | CISPLATIN + GEMCITABINE |
| 320002964 | 320001764 | 1.6 | 65 | Curative (C) | 2013-05-07 | 2013-05-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 320017457 | PACLITAXEL |
| 320002965 | 320006302 | null | 41.3 | Curative (C) | 2014-07-20 | 2014-07-20 | FEC 100 | N | N | 320017461 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002966 | 320006302 | null | null | Curative (C) | 2015-07-27 | 2015-08-11 | Capecitabine (21days) + Carboplatin | N | Y | 320017461 | ICON TRIAL |
| 320002967 | 320001765 | 1.51 | 54.25 | Curative (C) | 2015-03-06 | 2015-03-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 320017480 | PEMBROLIZUMAB |
| 320002968 | 320001765 | 1.61 | 90 | Palliative (P) | 2017-07-09 | 2017-11-08 | POUT TRIAL | 02 | N | 320017480 | CETUXIMAB + RT |
| 320002969 | 320001766 | 1.67 | 108 | Disease modification (D) | null | 2014-11-18 | TIP | N | N | 320017490 | CISPLATIN + GEMCITABINE |
| 320002970 | 320001766 | 1.74 | 77.6 | Neo-adjuvant (N) | 2016-11-08 | 2016-11-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320017490 | NOT MATCHED |
| 320002971 | 320001767 | 1.69 | 64.7 | Palliative (P) | 2015-11-12 | 2015-11-26 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320017493 | TEMOZOLOMIDE + RT |
| 320002972 | 320004919 | 1.65 | 125.9 | Palliative (P) | 2016-05-10 | 2016-05-18 | GEMCITABINE | N | N | 320017496 | VEMURAFENIB |
| 320002973 | 320001768 | 1.64 | 73.5 | Palliative (P) | 2016-11-22 | 2016-10-31 | Abiraterone | null | Y | 320017499 | LOMUSTINE |
| 320002974 | 320001768 | 1.68 | null | Palliative (P) | null | 2015-07-27 | Bevacizumab 7.5mg/kg | N | N | 320017499 | CISPLATIN + GEMCITABINE |
| 320002975 | 320001769 | null | 69.7 | Curative (C) | 2015-02-02 | 2015-02-27 | Trial Unspecified + CARBOPLATIN + GEMCITABINE | N | N | 320017510 | PEMBROLIZUMAB |
| 320002976 | 320004921 | 1.6 | 69.2 | Adjuvant (A) | 2015-11-27 | 2015-12-19 | IMATINIB | N | Y | 320017514 | CAPECITABINE + CISPLATIN |
| 320002977 | 320001770 | 1.68 | 91.8 | Adjuvant (A) | 2015-09-08 | 2015-09-11 | CISPLATIN + GEMCITABINE | N | N | 320017516 | CARBOPLATIN + RT |
| 320002978 | 320001770 | 1.72 | 71.7 | Curative (C) | 2013-08-23 | 2013-09-17 | POUT TRIAL | N | y | 320017516 | PAZOPANIB |
| 320002979 | 320001771 | null | 89.5 | Curative (C) | 2015-08-30 | 2015-08-30 | IPILIMUMAB + NIVOLUMAB | 99 | N | 320017521 | CETUXIMAB + RT |
| 320002980 | 320001772 | 1.7 | 69.3 | Adjuvant (A) | 2016-01-23 | 2016-02-13 | Trial Unspecified | N | N | 320017523 | TRIAL |
| 320002981 | 320001773 | 1.72 | 101 | Palliative (P) | null | 2016-07-09 | Temozolomide 150mg/m2 | null | null | 320017526 | CISPLATIN + ETOPOSIDE |
| 320002982 | 320001774 | 1.64 | 178 | Palliative (P) | 2016-09-17 | 2016-10-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320017535 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002983 | 320001775 | 1.73 | 62 | Palliative (P) | 2015-11-28 | 2015-11-28 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 320017552 | GEMCITABINE |
| 320002984 | 320001776 | 1.58 | 54 | Palliative (P) | 2015-06-28 | 2015-07-13 | Bevacizumab 15mg/kg | N | N | 320017559 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 320002985 | 320001777 | 1.8 | 0 | Palliative (P) | 2017-02-16 | 2017-02-18 | CETUXIMAB + RT | 02 | N | 320017561 | CETUXIMAB + RT |
| 320002986 | 320001778 | 1.78 | 79 | Curative (C) | 2016-05-29 | 2016-06-19 | Capecitabine + Cisplatin | N | N | 320017569 | ENZALUTAMIDE |
| 320002987 | 320001779 | 1.81 | 83 | Palliative (P) | 2016-09-02 | 2016-09-02 | Cetuximab + Radiotherapy Load | 02 | N | 320017573 | DACARBAZINE |
| 320002988 | 320001780 | 1.09 | null | Palliative (P) | 2018-09-26 | 2018-10-03 | Cetuximab + Radiotherapy Load | N | null | 320017579 | CARBO + FLUOROURACIL |
| 320002989 | 320001781 | null | 59.2 | Curative (C) | 2013-04-17 | 2013-04-29 | Carboplatin + Doxorubicin | null | null | 320017585 | IPILIMUMAB + NIVOLUMAB |
| 320002990 | 320001782 | 1.67 | null | null | 2014-09-29 | 2014-10-01 | CETUXIMAB + RT | null | null | 320017593 | CISPLATIN + GEMCITABINE |
| 320002991 | 320001783 | 1.56 | 54.8 | Palliative (P) | 2015-04-19 | 2015-05-02 | PEG INTERFERON | 02 | N | 320017595 | CISPLATIN + GEMCITABINE |
| 320002992 | 320001783 | 1.72 | 89.4 | Palliative (P) | 2018-01-02 | 2018-01-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320017595 | GEMCITABINE |
| 320002993 | 320001783 | 1.7 | 77 | Curative (C) | 2016-06-18 | 2016-07-16 | PACLITAXEL | N | Y | 320017595 | CAPECITABINE + CISPLATIN |